| Searcy Physical Therapy | |
|
801 W Beebe Capps Expy, Searcy, AR 72143-6353 | |
| (501) 268-2513 | |
| (501) 279-1328 |
| Full Name | Searcy Physical Therapy |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 801 W Beebe Capps Expy, Searcy, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043296981 | NPI | - | NPPES |
| 5F407 | Other | AR | BLUE CROSS BLUE SHIELD |
| 157701742 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Andrew P Abraham |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750362729 PECOS PAC ID: 0749184125 Enrollment ID: I20031126000422 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Trina C Abraham |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1164408001 PECOS PAC ID: 0749289098 Enrollment ID: I20061214000020 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Timothy Chung |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1356674998 PECOS PAC ID: 9638215049 Enrollment ID: I20091014000729 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Matthew B Calhoun |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1538683420 PECOS PAC ID: 2769756733 Enrollment ID: I20170914003849 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Gary P Anzalone |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1366966293 PECOS PAC ID: 2769756667 Enrollment ID: I20170915001280 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Haley A Main |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902320831 PECOS PAC ID: 5092089904 Enrollment ID: I20170915001499 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Jordan W Taylor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1538544606 PECOS PAC ID: 5597014878 Enrollment ID: I20180820002502 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Lexis A Blackburn |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962980409 PECOS PAC ID: 8224389663 Enrollment ID: I20180924001497 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Grant M Hallbauer |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1336772904 PECOS PAC ID: 7810326071 Enrollment ID: I20200409000910 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Jacob Wade Tomlinson |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1235783770 PECOS PAC ID: 6608273040 Enrollment ID: I20210927003517 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Kyle Madden |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1093480550 PECOS PAC ID: 3779981139 Enrollment ID: I20211015000411 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Caitlin Garfield |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1003495862 PECOS PAC ID: 6002214319 Enrollment ID: I20211018000134 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Michaela Lyle |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710615257 PECOS PAC ID: 5597149823 Enrollment ID: I20220905000338 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Koby Keith Hartis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1386278836 PECOS PAC ID: 5597110676 Enrollment ID: I20231010000809 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Provider Name | Adrian Cooper |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1962184028 PECOS PAC ID: 2769837574 Enrollment ID: I20231016000031 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Searcy Physical Therapy 801 W Beebe Capps Expy, Searcy, AR 72143-6353 Ph: (501) 268-2513 | Searcy Physical Therapy 801 W Beebe Capps Expy, Searcy, AR 72143-6353 Ph: (501) 268-2513 |
News Archive
As Congress prepares to return this week, the Sunday talk shows included talk of compromise, though there are fears of even more partisan fighting in the next Congress.
Late-onset Alzheimer's disease, the one that appears after age 65, is the most common form of this neurodegenerative disease and accounts for more than 90% of cases.
The U.S. Food and Drug Administration has approved AbbVie's VIEKIRA PAK, an all-oral, interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, including those with compensated cirrhosis.
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, announced today the issuance of two key patents related to the company's Senza High-Frequency Spinal Cord Stimulation System.
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for achieving optimal care for older cancer patients.
› Verified 2 days ago
Caitlin Garfield, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 801 W Beebe Capps Expy, Searcy, AR 72143 Phone: 501-268-2513 Fax: 501-279-1328 | |
Mr. Louis Frank Reaper, PT MS GCS Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 2918 Hawkins Dr., Searcy, AR 72143 Phone: 501-279-9255 Fax: 501-279-9257 | |
Colt Huggins, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 W Beebe Capps Expy, Searcy, AR 72143 Phone: 501-268-2513 Fax: 501-279-1328 | |
Chandler Wilson Ferren, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 710 Marion St, Searcy, AR 72143 Phone: 501-278-8370 | |
Mr. Jacob Everett Lester, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 102 Apache Dr, Searcy, AR 72143 Phone: 318-268-4851 | |
Hugh Lindsey Kleypas, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2900 Hawkins Dr, Searcy, AR 72143 Phone: 501-278-2800 Fax: 501-278-3001 |